Prostate Cancer Treatment

Clive Jones Excerpts

Tuesday 17th June 2025 Commons Chamber

[Dr Rupa Huq (Ealing Central and Acton) (Lab)]

Joe Biden’s recent diagnosis has to some extent put prostate cancer in the spotlight of late, but it is not just him—there is Stephen Fry, Jools Holland and Robert De Niro. More than 50,000 men in the UK and 1.4 million men worldwide are diagnosed with prostate cancer yearly, which is projected to double by 2040. With one in eight men diagnosed during their life, it is the most common male cancer. More than half of those men are pre-retirement age, such as the cyclist Sir Chris Hoy, who was diagnosed at 48, but 70-plus is the most common age.

My late dad was 69 when he was diagnosed. He left this earth just shy of his 79th birthday in August 2014, so he had 10 years. It is often said that men die with prostate cancer, not of it. With my dad, it spread to bone cancer, but pneumonia was actually the cause of death on the certificate. I miss him every day.

Treatment for prostate cancer has improved dramatically since then. One crucial breakthrough is the development of the drug abiraterone, a Great British success story discovered and initially developed in London at the Institute of Cancer Research. It is a shining example of British science leading the world and revolutionising advanced prostate cancer care.

[Clive Jones (Wokingham) (LD)]

Will the hon. Member reiterate a question that I have for the Minister? Specifically, given that abiraterone is already approved for use in Scotland and Wales, what action is the Minister taking to ensure that men in England are not disadvantaged in accessing lifesaving cancer treatments?

[Dr Huq]

The hon. Member reads my mind about the postcode lottery, which I will come to in my list of questions. I know that my hon. Friend the Minister is very sympathetic and on the right side.

Abiraterone is now a global drug. Half a million men around the world have had transformed outcomes, improved quality of life and extra years spent with loved ones.

Oral Answers to Questions

Clive Jones Excerpts

Tuesday 17th June 2025 Commons Chamber

[Wes Streeting]

My hon. Friend is absolutely right. Just as this Government are delivering record home building with a huge target to build the homes that Britain needs, we also need to ensure that people get the local services that they deserve. That is exactly why this Government have invested an extra £102 million this year to create additional clinical space in over 1,000 GP practices, which will create new consultation rooms and make better use of existing space to deliver more appointments. I know the Chineham medical practice was one of the practices put forward by its integrated care board for funding, so I hope we will see that practice benefiting from this investment in the near future as we rebuild our NHS.

[Clive Jones (Wokingham) (LD)]

The Government’s additional roles reimbursement scheme led to just three new GPs for my constituents in Wokingham, which is a drop in the ocean. More needs to be done to deliver GP practices in new developments such as Arborfield in south Wokingham. Why did Ministers not support the Liberal Democrat amendment to the Planning and Infrastructure Bill that would have made commitments to build GP surgeries in all new housing developments legally binding?

Spending Review: Health and Social Care

Clive Jones Excerpts

Thursday 12th June 2025 Commons Chamber

[Karin Smyth]

My hon. Friend has been such a strong and powerful campaigner for women’s health since becoming an MP last year, and she is absolutely right to do that. I am pleased that we have been able to make some progress on conditions such as endometriosis. Many campaigns have been fought by many women in this House—including you, Madam Deputy Speaker, if I may say so—to highlight the importance of this issue. We see women’s health as front and centre. We want to learn from the women’s health hubs in their different guises and ensure that they are an integral part of neighbourhood health services.

[Clive Jones (Wokingham) (LD)]

I was really saddened that there was no mention of cancer in the Minister’s statement, so I will give her the opportunity to correct that omission. Will this new money for our NHS ensure that all cancer waiting time targets are met by the end of this Parliament, and can the Minister confirm that those targets will be included in the 10-year health plan? Finally, have Ministers had a chance to read my 11-page letter and accompanying submission on what should be in the national cancer plan?

[Karin Smyth]

I have a slight “get out of jail free” card, because I think that letter might be with one of my colleagues, not with me. Obviously, though, I look forward to the summary.

The hon. Gentleman makes a really important point about cancer. I would have to check, but I do not think I mentioned lots of disease-specific areas, including key manifesto commitments such as dentistry. Obviously, cancer is a huge part of waiting lists overall. We will get those waiting lists down—we are determined to meet that target—and we will issue a cancer plan later in the year.

GP Services: Christchurch

Clive Jones Excerpts

Tuesday 20th May 2025 Westminster Hall

[Sir Christopher Chope]

The hon. Gentleman mentions the issue of finances. I tabled a written question about how much the health service has been spending on general practice in the Christchurch constituency. Again, rather surprisingly, the information is available only for the year ending 2023, so we do not have any information for 2023–24. Although I would not expect the figures for 2024–25 to be available, I certainly would have expected the total costs for 2023–24 to be available by now. The answer says that in 2022–23, some £17.5 million was spent on providing GP services in Christchurch.

The idea that the cost of transferring patients from one practice to another should be a decisive factor against the reopening of a branch seems extraordinary. It makes a nonsense of the argument that we must rein in our expenditure. While we are talking about the ICB’s expenditure, for the last several years I have been complaining that, at any given time in Dorset, under the ICB’s supervision, there are some 250 patients in Dorset hospitals who have no need to “reside”, as it is called. In other words, those people are in hospital but do not need to be there. Every day, that is 250 patients at a cost of between £500 and £1,000 each.

The same body is presiding over that scandal. It said last year that it was going to halve the number, but it has failed to do so—indeed, the number is just the same as a year ago. Instead of taking it out on the people of Christchurch and saying, “You can’t have access to a reopened branch surgery,” it should be looking at its own poor performance. As I have said to the Minister informally, the idea that Dorset ICB will somehow be amalgamated with other ICBs—creating even more bureaucracy, and making it even more remote from the people—is, again, farcical.

My final point—I want to give the Minister time to respond—is that, in answer to a written question, the Minister for Care said that as a result of what has happened in the last year, the number of patients in Highcliffe has increased by about 150. In Christchurch medical practice, the total number of patients has actually fallen; in the Stour surgery, it has increased; and in the Grove, it is about the same. To suggest, on those figures, that the financial viability of other practices in Christchurch will be threatened if this branch surgery is reopened seems to be without any justification. I hope that the Minister will be able to give a positive response, although I note that the Minister for Care is not responding to the debate.

[Clive Jones (Wokingham) (LD)]

Will the hon. Gentleman give way?

[Sir Christopher Chope]

I will not, because I want to ensure that the Minister has time to respond to those points.

[The Minister for Secondary Care (Karin Smyth)]

It is a pleasure to serve under your chairmanship this morning, Mr Dowd. I thank the hon. Member for Christchurch (Sir Christopher Chope) for raising GP surgeries, which is a vital matter to so many of our constituents. That is because GP surgeries are the front door to our NHS, and visiting a GP represents far better value for taxpayers’ money than accident and emergency departments. That is why, since coming into office, fixing general practice has rightly taken up a lot of our bandwidth, energy and focus.

It is worth remembering that we inherited a system in total disarray, and a bizarre situation in which we simultaneously had a GP shortage and newly qualified GPs looking for work. I am proud of everything we have done to turn GP services around in the nine or 10 short months we have had. However, before I come on to that, let me address some of the hon. Gentleman’s points.

Ahead of this debate, I asked my office to get in touch with the integrated care board locally so that we had a fuller picture of what is happening on the ground. My understanding is that Burton surgery was previously a branch of Christchurch medical practice, which is just under two miles away. The surgery closed in August last year because the owners wanted to sell. Although the ICB did not approve of the closure, it recognised that it had little influence over the sale as GPs are independent practitioners.

I am informed that the local community were—as they often are—understandably unhappy with the news about changes to the services, and that the hon. Gentleman got in touch with Dorset ICB. When a veterinary business tried to buy the site, the application received over 100 objection letters and the sale did not go ahead. The ICB then received two further applications to renew the site, about which it considered a number of factors, as is normal practice: whether there is good access to surgeries in the area; what the impact would be on patients and on community needs; how it would affect the quality, equity and safety of provision; and how it might affect the stability and ability of other local GP services to run viable surgeries in their area.

I have been assured that the decision that Dorset ICB took was not taken lightly but based on the needs of and the benefits to all prospective patients in the area. The surgery catchment area for Burton is covered by Christchurch medical practice and Farmhouse surgery. As the hon. Gentleman outlined, reopening would have required additional costs, which were not justifiable given the financial challenges facing the NHS—something that we all understand. Consequently, Dorset ICB felt that those costs would reduce provision in the area and lead to significant financial pressures on other local surgeries, which could lead to further closures.

Dorset ICB has seen no degradation of services for patients since the surgery closed and the number of appointments has not decreased overall. I take the hon. Gentleman’s point about the numbers, and I do not know why that information is not available; I am happy to take that question back to the Department. Local MPs should have as much information as possible about services in their areas. These are taxpayer-funded services, so I will check as to why that information is not available. Dorset ICB has not received what it calls formal complaints from patients, but it has received communications from a local campaigning group, which is important. On balance, however, it decided that it could not reopen the practice.

On the point about housing needs, which I talked about for many years when I was an Opposition Member of Parliament, the Government absolutely understand the issue of additional demand and the challenge it poses to primary care infrastructure.

[Clive Jones]

Will the Minister give way?

[Karin Smyth]

I will not, because the hon. Member for Christchurch wants me to answer his questions.

We are working closely with the Secretary of State for Housing, Communities and Local Government to address the issue of additional demand in national planning guidance and ensure that all new and existing developments have an adequate level of healthcare infrastructure for the community. The NHS has a statutory duty to ensure that there are sufficient medical services, including general practice, in each local area, with funding and commission reflecting population growth and demographic changes. The hon. Gentleman highlights an important point that we will continue to pursue.

Those are the facts about the decision made by the ICB, which was its decision to make. I am not going to stand here and tell the hon. Gentleman that he is not right to do what he is doing; he is absolutely right to fight for the best possible service provision for the people of Christchurch, and I would do the same for my constituents—all hon. Members do that. These decisions are best made locally, however, and it is for Dorset ICB to use its autonomy to make them, not Ministers in Whitehall.

Hospitals

Clive Jones Excerpts

Wednesday 23rd April 2025 Commons Chamber

[Clive Jones (Wokingham) (LD)]

I am proud to declare my interest as a governor of the Royal Berkshire hospital. The Royal Berks is an incredibly important place for me. I have been treated there many times, friends and family work there, and my constituents rely on the dedication of its hard-working staff. The way that this important community asset was treated by the previous Conservative Government is a scandal. They have left a record of broken promises and a building that in many places is literally crumbling.

Looking at the Conservative legacy, before the 2024 general election, they introduced a seven-year delay to the construction of the new hospital in 2023. That is a seven-year delay for something that was never funded in the first place. The Conservatives’ dithering and delays have resulted in £7 million being wasted at the Royal Berkshire hospital on surveys, investigations and the development of a hospital programme that was never going to go anywhere, and the Conservatives knew that all the time. Their behaviour over the last five years has been shameful, and they have deceived my constituents.

My hon. Friend the Member for Henley and Thame (Freddie van Mierlo) has highlighted many of the issues at the Royal Berkshire, so I will not repeat his points, but there is a maintenance backlog amounting to £102 million, and staff have recently told me that an additional £300 million is needed for maintenance. Will the Minister confirm that there will be a proper maintenance programme for the next 20 years? I have to thank her for her guarantee that when the Royal Berkshire NHS Foundation Trust requires funds to purchase land for the new site, her Department will provide those funds. I would be grateful if she could confirm that that position has not changed, and also that the planned cuts and savings at the trust to balance its budget will have no impact on its ability to deliver vital maintenance at the hospital site.

[Madam Deputy Speaker (Ms Nusrat Ghani)]

I call Danny Chambers to wind up the debate for the Liberal Democrats.

Rare Cancers Bill

Clive Jones Excerpts

2nd reading
Friday 14th March 2025 Commons Chamber

[Clive Jones (Wokingham) (LD)]

I have to say, Madam Deputy Speaker, that as I was waiting to speak, I was very pleased that you did not call me after the hon. Member for Calder Valley (Josh Fenton-Glynn) because I do not think I would have been able to get through parts of my speech so shortly after listening to his story; he did really well.

I was diagnosed with breast cancer in 2008, which is relatively unusual for a man, and the hardest thing I ever had to do was tell my two daughters, who were 13 and 14 at the time, about my diagnosis. It was an experience that left me wondering if our family of four was about to become a family of three. I had to explain to all of them that I would have an operation to remove a tumour and I might need another one. As things turned out, my cancer had spread and I did need to have another operation. I also had to say that I would need chemotherapy and radiotherapy, and that that was going to take nine months out of our lives—not just mine, but the lives of my immediate family, my wider family and our friends.

I consider myself very lucky that my treatment pathway was relatively clear, but that is not the case for many rare cancers. The reach of cancer is an evil that is growing across our society with nearly one in two of us projected to get cancer in our lifetime, meaning we all know someone close to us, whether family or friend, who will begin what can be a very traumatic journey. It is a fight that causes your life to be taken completely out of your hands, and that leaves families forced to hear rarely used terms like “malignant” or “metastasised” as if they were common expressions, clouding the horror of medical jargon.

It is with these words that I am proud to associate myself with the hon. Member for Edinburgh South West (Dr Arthur), and I congratulate him on his campaign that demands better for cancer patients and especially on bringing forward the Rare Cancers Bill, because it is a powerful and necessary step forward to end the experience that I described at the beginning of my speech.

Rare cancers are often under-researched and the regulatory environment simply fails to cope with them. They have smaller patient populations which makes research and investment less appealing and an evidence base harder to achieve. Where clinical trials are taking place, patients often do not know very much about them. A Cancer52 survey of rare cancer patients found that 65% cited not knowing about trials as the main barrier to accessing the trial in the first place. The Bill seeks to rectify those flaws in our system, and I would like to highlight the powers it contains to ensure that patients can get better access and find relevant clinical trials. As was highlighted in the Teenage Cancer Trust’s “Improving Young People’s Access to Cancer Clinical Trials” report, it is also difficult for the clinical trial leads themselves to find the necessary patients, meaning that they struggle to recruit. Both patients and researchers want to be in those clinical trials, but the system does not allow for that common-sense joining up.

I hope that as a result of the changes made by the Bill, people in my constituency of Wokingham and across England will begin to see a shift towards prioritising rare cancers, because such a shift is long overdue. Last week, I met a constituent to discuss his wife’s cancer. She had leiomyosarcoma, which has an incidence rate of six cases per 1 million people annually in the UK. He explained to me that one of the potential treatment options for his wife is exploiting faults in the BRCA2 genes through PARP inhibitors. However, with an estimated 30 new cases of leiomyosarcoma every year and only three with the BRCA2 mutation, there are too few patients to allow for a sufficient clinical trial, and therefore NICE does not license those drugs for that particular cancer.

What are the Minister’s views on efforts within the European Union’s life science industry to develop clear guidance to make cross-border clinical trials easier? If that were to happen, it would address one of the major problems with rarer cancers such as leiomyosarcoma. Individual nations may not have a sufficient pool of patients to conduct a clinical trial, but multiple nations working together could. Does the Minister see cross-nation trials as having great potential for developments in oncology? If the EU were to advance easier cross-border co-operation, would that be something that the United Kingdom could potentially negotiate its way into? This is no time for a Government to be isolationist.

My constituent also highlighted that PARP inhibitors are available in the United States. What efforts is the Minister making to ask that if drugs are approved by the United States Food and Drug Administration, NICE has the opportunity to take the US evidence into account when considering whether to approve licences for drugs in the UK?

Sarcomas are just one tumour type that has poor survival outcomes and limited treatment options. Despite the investment by charities such as Sarcoma UK to fund research into new treatments, we do not know enough about the disease, because so few people are affected. Other constituents have written in to share their experience of losing loved ones to brain tumours such as glioblastomas and to blood cancers. All have expressed hope that this Bill will create a world in which we can better encourage pharmaceutical companies to run trials on rarer cancers in order to create innovative new treatments, so that the pain they went through will not be a fate that others must endure in future.

Before I conclude, it would be a missed opportunity if I did not ask the Minister about the national cancer strategy, which will be so important in ensuring that a long-term plan is in place to deliver better services for patients with rare and less common cancers. The NHS needs to be prepared for the innovations of the future by preparing for an increase in demand for companion diagnostics. The turnaround times for existing tests are already causing delays in optimal treatments. What steps is the Minister taking to ensure that there is enough capacity for the ever-increasing demand for diagnostic tests?

The national cancer strategy needs to be thoroughly scrutinised before its final draft is published, to ensure that the measures demanded by cancer charities and patient groups, and ideas from by the life sciences sector, are properly covered. NHS performance must be measured regularly over the lifetime of the strategy to see if improvements are actually being made. Will the Minister explain what accountability mechanisms are being considered for the national cancer strategy?

I thank the hon. Member for Edinburgh South West once again for bringing the Bill to the House.

Accessibility of Radiotherapy

Clive Jones Excerpts

Tuesday 4th February 2025 Westminster Hall

[Clive Jones (Wokingham) (LD)]

It is a pleasure to serve under your chairship, Sir John. I thank my hon. Friend the Member for Westmorland and Lonsdale (Tim Farron) for securing this debate and for his dedication on this issue. I declare an interest as a governor of the Royal Berkshire hospital. I also have a family member who has shares in a medical company.

Radiotherapy access suffers from geographical constraints, and this issue cannot be solved until the significant workforce challenge is addressed alongside it. The Royal College of Radiologists states that in England the NHS faces a 30% shortfall in radiologists. That figure is projected to rise to 40% by 2028, yet more than a fifth of NHS trusts have implemented recruitment freezes. Shortfalls in recruitment mean that consultants, faced with burnout and impossible workloads, retire earlier. That is made especially clear as the average age of retirement is just 54.

The Royal College of Radiologists highlights the absurd situation whereby newly trained consultants may struggle to find jobs, forcing invaluable radiologists and oncologists to go for locum jobs, move abroad or leave the healthcare sector altogether at a time when their skills are best placed in our NHS to fix our cancer care crisis—a crisis in which not a single integrated care board is currently meeting its cancer waiting time standards.

The impact of the recruitment freezes on patients is tangible and is not limited to radiotherapy. Some 80% of patient pathways in the NHS are reliant on radiology. Delays in scan reporting result in delayed treatment. Delayed treatment results in worse outcomes. Worse outcomes may be the deciding factor in whether someone fails to recover.

How will the Government ensure that when my Wokingham constituents visit the Royal Berkshire hospital, the oncology and screening departments are fully staffed? Can the Minister explain his understanding of the recruitment freezes that are taking place across NHS trusts? I am aware that the Minister has a very, very busy diary: he told me so earlier today in the main Chamber.

[The Parliamentary Under-Secretary of State for Health and Social Care (Andrew Gwynne)]

I suspect that my diary will be a little busier with the two requests from the hon. Member for Westmorland and Lonsdale (Tim Farron).

[Clive Jones]

The Minister’s diary will be a little busy, but I am sure it can cope. I ask him to meet me and representatives of the Royal College of Radiologists to discuss the Government’s plan for workforce reform.

[Sir John Hayes (in the Chair)]

I am delighted to be able to call the Front-Bench spokesmen early, although that does not necessarily mean that they have to go on at immense length. I call the Liberal Democrat spokesman.

National Cancer Plan

Clive Jones Excerpts

Tuesday 4th February 2025 Commons Chamber

[Andrew Gwynne]

Part of our recovery plan is to ensure that we return the national health service to constitutional standards, not just in respect of cancer but across the board. We inherited a broken national health service and it is incumbent on this Government to fix it and make it fit for the future. Clearly, in areas such as my hon. Friend’s, the NHS needs to be doing much better when it comes to cancer outcomes and cancer treatments, and this plan and this Government will ensure that his local system gets all the support it needs.

[Clive Jones (Wokingham) (LD)]

I declare an interest, as I have a family member who has shares in a medical company.

I pay tribute to the Minister for following through with his promise for a national cancer plan. It is clearly very important to him, and it is to me as well. Shaun Walsh of Cancer Research UK first raised with me the need for a dedicated cancer plan, and it has been an important part of my work in Parliament since then. Will the Minister meet me and Shaun to discuss the next steps for the national cancer plan?

[Andrew Gwynne]

I am more than happy to do so. My diary secretary, who will be watching this from the Department of Health, is probably having kittens at the amount of meetings. I meet Shaun and the cancer charities frequently anyway, and as I said at the start of the statement, I commend the work that they do in this area. This national cancer plan is important to me, to the Secretary of State, to the Prime Minister and to the sector, and that is why we are doing the right thing and having a plan.

New Hospital Programme

Clive Jones Excerpts

Wednesday 22nd January 2025 Westminster Hall

[Dr Kieran Mullan (Bexhill and Battle) (Con)]

I beg to move,

That this House has considered the New Hospital Programme.

It is a pleasure to serve under your chairmanship, Dr Huq, for a debate that is very timely in the light of the statement of the Secretary of State for Health and Social Care this week. My remarks will focus on three hospitals that serve my constituency as part of the East Sussex healthcare NHS trust: Eastbourne district general hospital and Conquest hospital, which are situated outside my constituency but are major secondary care providers for my constituents, and Bexhill community hospital.

As part of the new hospital programme announced by the previous Government, Eastbourne district general hospital is due to be entirely rebuilt, and Conquest hospital is set to be reorganised and the structure improved to ensure that it is fit for the future. Alongside creating additional in-patient wards and improved parking facilities, the plans include expanding the emergency departments at Eastbourne and Conquest, improving access to cardiology and ophthalmology services, and redeveloping out-patient theatres, endoscopy and diagnostic services.

Plans to upgrade Bexhill community hospital are also included in the programme, equipping it to deliver more services locally. Currently, only 53% of space in the hospital is allocated to clinical space. Once that work is complete, that will increase to 70%. To reflect increasing demand for care, the plans will also increase the number of hospital beds by 13%, the number of single rooms as a proportion of hospital space from 18% to 70%, and the number of out-patient consulting rooms by 28%.

Having worked in the NHS as a doctor in A&E for a number of years before becoming an MP, I know the difficulties that can arise from working in buildings that are in need of improvement. The physical infrastructure of the building is outside the control of frontline staff, so they often have to do whatever it takes to make it work, but it would be better if they did not have to. I think the Minister would agree that despite those circumstances, our healthcare staff work tirelessly, and we owe it to them to deliver better infrastructure.

Whatever the new Government may say, progress on the new hospital programme was being made under the previous Government, despite the challenges presented by the pandemic and the inflationary pressures on construction costs as a result of the war in Ukraine. The programme was incredibly ambitious but remained a significant commitment to investment in hospital infrastructure.

During the 2024 general election, the Labour party committed to delivering the new hospital programme. Candidates up and down the country made pledges to deliver on the programme, but this week, the Health Secretary broke that pledge at the Dispatch Box by moving the goalposts, as a result of which many constituents in Bexhill and Battle will not see the benefits of the programme until 2039 at the earliest.

[Clive Jones (Wokingham) (LD)]

I declare my interest as a governor of the Royal Berkshire hospital, and that a family member has shares in a medical company. My constituents are heartbroken by the Government’s decision to push the start date of the Royal Berks’s construction to 2037, which will disappoint patients and staff. The hon. Member must recognise the role that his party played in creating that situation, so does he agree that his party needs to reflect on its part in the delayed new hospital programme, and will he apologise for it?

[Dr Mullan]

It is a 30-minute debate, and I want to be generous in letting hon. Members make short points in support of their hospitals, but I do not want to allow it to degenerate into a highly political back and forth. As I was saying, the Government pledged to do it and they did not.

--- Later in debate ---

[Karin Smyth]

I thank my hon. Friend for her intervention, which highlights the point that the hon. Member for Bexhill and Battle raised about other capital plans and programmes to help his constituents and others over the coming years.

In conclusion, I thank the hon. Gentleman for raising this issue.

[Clive Jones]

rose—

[Dr Mullan]

rose—

Health and Social Care: Winter Update

Clive Jones Excerpts

Wednesday 15th January 2025 Commons Chamber

[Wes Streeting]

I would be very happy to write to my hon. Friend to set out the support provided by NHS England to health and care services for his community, and I would be delighted to receive via him feedback from his health and care providers about what Government support they would like next winter and in future years.

[Clive Jones (Wokingham) (LD)]

I declare my interest as a governor of the Royal Berkshire hospital, and I have a family member who has shares in a medical company.

The Secretary of State has a really tough job of clearing up the mess left in the NHS by the Conservatives, but some of the Royal Berkshire hospital estate is not fit for purpose and especially not fit to cope with the winter crisis. Can he confirm that a proper level of funding will be available to rebuild the Royal Berkshire hospital and that there will be no increase in the seven-year delay announced by the Conservatives in April this year? That will help with future winter crises.

[Wes Streeting]

I will take that as another representation from the hon. Gentleman on the new hospital programme, and I reassure him we will be setting out our review and its conclusions shortly.